Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Intravenous Lidocaine Infusion in Children
NCT02241096Phase 1Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Lidocaine Hydrochloride Injection, without epinephrine in Colorectal disease, sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Safe serum levels of lidocaine infusion. Started Jan 2015; status: terminated.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Colorectal disease
Beyond the preview
Go deeper on NCT02241096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241096.